# The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin

Study · id `cardio:ct-nct02726555` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02726555](<https://clinicaltrials.gov/study/NCT02726555>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02726555

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

## Technical summary

Registry record NCT02726555. Randomized; double masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2026-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT02726555, source copy `cardio:ctgov-nct02726555-2024-08-06`, retrieved 2026-10-31)
- Started: 2015-11 (actual) (ClinicalTrials.gov record NCT02726555, source copy `cardio:ctgov-nct02726555-2024-08-06`, retrieved 2026-10-31)
- Primary completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT02726555, source copy `cardio:ctgov-nct02726555-2024-08-06`, retrieved 2026-10-31)
- Completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT02726555, source copy `cardio:ctgov-nct02726555-2024-08-06`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02726555, source copy `cardio:ctgov-nct02726555-2024-08-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02726555-2024-08-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin
- Condition: Dyslipidemia
- Condition: Atherosclerosis
- Intervention (Drug): Red yeast rice and atorvastatin
- Intervention (Drug): Atorvastatin alone
- Lead sponsor: Wenzhou Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)

## Provenance

Content hash: 57c73ecdece890837732c49aefea4cf687cd4c7e485ebc891a31d79c1eff6451
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
